Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival.
Saved in:
| Title: | Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. |
|---|---|
| Authors: | Perrone, Elisabetta1,2,3 (AUTHOR) elisabetta.perrone@guest.policlinicogemelli.it, Calcagni, Maria Lucia2,3 (AUTHOR), Leccisotti, Lucia2,3 (AUTHOR), Moretti, Roberto4 (AUTHOR), Ghai, Kriti1 (AUTHOR), Eismant, Aleksandr1,2 (AUTHOR), Parkar, Tanay1,3 (AUTHOR), Greifenstein, Lukas1,4 (AUTHOR), Baum, Richard Paul1 (AUTHOR) |
| Source: | Cancers. Sep2025, Vol. 17 Issue 18, p3070. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 188283475 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Perrone%2C+Elisabetta%22">Perrone, Elisabetta</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> elisabetta.perrone@guest.policlinicogemelli.it</i><br /><searchLink fieldCode="AR" term="%22Calcagni%2C+Maria+Lucia%22">Calcagni, Maria Lucia</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leccisotti%2C+Lucia%22">Leccisotti, Lucia</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moretti%2C+Roberto%22">Moretti, Roberto</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghai%2C+Kriti%22">Ghai, Kriti</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Eismant%2C+Aleksandr%22">Eismant, Aleksandr</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Parkar%2C+Tanay%22">Parkar, Tanay</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Greifenstein%2C+Lukas%22">Greifenstein, Lukas</searchLink><relatesTo>1,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baum%2C+Richard+Paul%22">Baum, Richard Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Sep2025, Vol. 17 Issue 18, p3070. 16p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188283475 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers17183070 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 3070 Titles: – TitleFull: Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Perrone, Elisabetta – PersonEntity: Name: NameFull: Calcagni, Maria Lucia – PersonEntity: Name: NameFull: Leccisotti, Lucia – PersonEntity: Name: NameFull: Moretti, Roberto – PersonEntity: Name: NameFull: Ghai, Kriti – PersonEntity: Name: NameFull: Eismant, Aleksandr – PersonEntity: Name: NameFull: Parkar, Tanay – PersonEntity: Name: NameFull: Greifenstein, Lukas – PersonEntity: Name: NameFull: Baum, Richard Paul IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 09 Text: Sep2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 20726694 Numbering: – Type: volume Value: 17 – Type: issue Value: 18 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |